Obtaining the prestigious PMDA certification in Japan.

After more than two years of intense work, we are proud to announce the obtaining of the prestigious authorization to sell for EchoS device in Japan issued by the PMDA Japan: Pharmaceuticals and Medical Devices Agency of Japan.

The important milestone is a further international recognition for Echolight obtained through a scrupulous work with the Japanese agency and the commercial partner Toyo Medic, a consolidated reality in the distribution of innovative medical devices that has signed an important exclusive sales agreement in the Japanese territory for the Echolight range of products.

In Japan, the issue of bone health is so crucial that the Japanese Ministry of Health, Labor and Welfare has undertaken a survey to quantify the costs related to deficiencies in bone density and structure, as well as the costs related to fractures in the older population. age 65 and it has been estimated that total costs have been nearly 944 billion Japanese yen (8 billion US dollars) and are increasing rapidly.

With the introduction of R.E.M.S. Japan is at the forefront in the diagnosis of osteoporosis, demonstrating its foresight by adopting a new concept of bone health based on prevention, early diagnosis and monitoring throughout the whole life aimed at reducing the risk of fragility fracture with direct benefits towards patients as well as the sustainability of their healthcare system.

In fact, the revolutionary EchoS device, for bone micro-architecture assessment of the lumbar vertebrae and the femoral neck, based on the proprietary and patented R.E.M.S. (Radiofrequency Echographic Multi Spectrometry), being radiation-free, fast, portable and accurate, it significantly increases the accessibility to the test for the entire Japanese population, favoring prevention and early diagnosis.

The expansion of Echolight and the adoption of R.E.M.S. by an ever-growing number of countries, now numbering over 40 around the world.

For more information:

https://bonehealth.echolightmedical.com/

REMS & Osteoarthritis

REMS & Osteoarthritis

“The advantages of REMS technology in the evaluation of BMD in a population with osteoarthritis of the lumbar spine.” Caffarelli et al, Diagnostics 2024 Carla Caffarelli 1, Antonella Al Refaie 1 Caterina Mondillo 1 Giuditta Manasse 1 Alessandro Versienti 1 Maria Dea...

read more
CPT code for REMS in USA

CPT code for REMS in USA

REMS obtains CPT Code in the USA In 2023 the American Medical Association (AMA) – CMS assigned a CPT code for the reimbursement of REMS bone assessment, officially applicable from January 2024. This important milestone arrived after a long process and strict...

read more
Paper of the Month

Paper of the Month

ESCEO: REMS PUBLICATION WINS "THE PAPER OF THE MONTH"   "“Longitudinal changes of the femoral bone mineral density from first to third trimester of pregnancy: bone health assessment by means of non‑ionizing REMS technology” Ruben Ramirez Zegarra1 Valentina...

read more

    Contact Us

    More info or book a demo.



    Position*

    *Required fields




    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.